Sign up
Log in
Why DocuSign Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Share
Listen to the news

Shares of DocuSign, Inc. (NASDAQ:DOCU) rose sharply in today's pre-market trading r after the company reported better-than-expected third-quarter financial results and issued FY25 revenue guidance above estimates.

DocuSign reported third-quarter revenue of $754.8 million, beating the consensus estimate of $745.26 million. The company reported third-quarter adjusted earnings of 90 cents per share, beating analyst estimates of 87 cents per share, according to Benzinga Pro.

DocuSign shares jumped 14.1% to $95.43 in the pre-market trading session.

Here are some other stocks moving in pre-market trading.

Gainers

  • Universe Pharmaceuticals INC (NASDAQ:UPC) gained 196.2% to $3.11 in pre-market trading after dipping 41% on Thursday.
  • Zhibao Technology Inc. (NASDAQ:ZBAO) rose 111.7% to $5.08 in pre-market trading after the company announced they will partner with PICC & Munich Re to develop new medical insurance products in China.
  • Color Star Technology Co., Ltd. (NASDAQ:ADD) gained 82.2% to $6.94 in pre-market trading after the company announced that it regained Nasdaq compliance.
  • Gaxos.ai Inc. (NASDAQ:GXAI) gained 48.6% to $2.11 in pre-market trading after gaining over 10% on Thursday.
  • The Lion Electric Company (NYSE:LEV) gained 43.3% to $0.48 in pre-market trading. Lion Electric reached a definitive agreement in respect of the sale of Innovation Center located in Mirabel, Québec for a purchase price of C$50 million.
  • Primega Group Holdings Limited  (NASDAQ:PGHL) rose 40.1% to $1.87 in pre-market trading after dipping over 15% on Thursday.
  • Rubrik, Inc. (NYSE:RBRK) gained 23.2% to $66.11 in pre-market trading as the company reported better-than-expected results for its third quarter.
  • Asana, Inc. (NYSE:ASAN) climbed 21.3% to $18.75 in pre-market trading after the company reported better-than-expected third-quarter financial results and issued FY25 guidance above estimates.
  • Satellogic Inc. (NASDAQ:SATL) gained 12.1% to $3.52 in pre-market trading after jumping 20% on Thursday.

Losers

  • Oriental Rise Holdings Limited (NASDAQ:ORIS) shares tumbled 81.23 to $10.50 in pre-market trading after surging 599% on Thursday.
  • zSpace, Inc. (NASDAQ:ZSPC) declined 31.7% to $15.01 in pre-market trading after jumping 340% on Thursday.
  • Foxx Development Holdings Inc. (NASDAQ:FOXX) shares fell 24.7% to $3.73 in pre-market trading after jumping 55% on Thursday.
  • PainReform Ltd. (NASDAQ:PRFX) shares fell 23.4% to $3.44 in pre-market trading. PainPerform shares jumped 68% on Thursday after the company announced changes in management including new CFO and CEO appointees.
  • Virpax Pharmaceuticals, Inc (NASDAQ:VRPX) fell 21.5% to $0.3069 in pre-market trading after declining around 5% on Thursday.
  • CAMP4 THERAPEUTICS CORPORATION (NASDAQ:CAMP) fell 21.4% to $7.71 in pre-market trading after gaining 66% on Thursday.
  • Protara Therapeutics, Inc. (NASDAQ:TARA) fell 17.9% to $4.94 in pre-market trading. Protare Therapeutics shares jumped 70% on Thursday after the company announced results from its ongoing Phase 2 TARA-002 trial in patients with NMIBC.
  • Molecular Templates, Inc. (NASDAQ:MTEM) dipped 17.1% to $0.4472 in pre-market trading after jumping 60% on Thursday.
  • Mawson Infrastructure Group Inc. (NASDAQ:MIGI) shares dipped 16.7% to $1.10 in pre-market trading after jumping 94% on Thursday.
  • Smith & Wesson Brands, Inc. (NASDAQ:SWBI) fell 15.8% to $11.48 in today's pre-market trading after the company reported second-quarter results.

Now Read This:

Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.
What's Trending
No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.